Showing results (241-250 of 2,883) with videos related to
Sort By:
Pageof 289
Journal of the American College of Cardiology|February 20, 2007
Endothelial progenitor cells in cardiovascular disordersEduard Shantsila, Timothy Watson, Gregory Y H LipThrombosis and Haemostasis|June 12, 2010
New oral anticoagulant drugs in cardiovascular diseaseIngo Ahrens, Gregory Y H Lip, Karlheinz PeterCurrent Vascular Pharmacology|July 15, 2010
Malignant hypertension: a rare problem or is it underdiagnosed?Alena Shantsila, Eduard Shantsila, Gregory Y H LipJournal of Cardiovascular Pharmacology and Therapeutics|September 17, 2013
Novel oral anticoagulants in cardiovascular diseasePilar Gallego, Vanessa Roldán, Gregory Y H LipThe Malaysian Journal of Medical Sciences : MJMS|April 24, 2013
The unmet need of stroke prevention in atrial fibrillation in the far East and South East AsiaYutao Guo, Gregory Y H Lip, Stavros ApostolakisCirculation|April 20, 2012
Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort studyLeif Friberg, Mårten Rosenqvist, Gregory Y H LipEuropean Heart Journal. Cardiovascular Pharmacotherapy|March 25, 2023
The neurocognitive effects of atrial fibrillation: benefits of the ABC pathwayPeter Calvert, Dhiraj Gupta, Gregory Y H LipCurrent Vascular Pharmacology|May 22, 2014
Primary prevention of ischaemic stroke in atrial fibrillation: new oral anticoagulant drugs for all?James Foley, Paulus Kirchhof, Gregory Y H LipInternational Journal of Clinical Practice|October 4, 2018
Time trends in use of the CHADS2 and CHA2 DS2 VASc scores, and the geographical and specialty uptake of these scores from a popular online clinical decision tool and medical referenceJoseph Habboushe, Caroline Altman, Gregory Y H LipExpert Opinion on Investigational Drugs|May 2, 2003
Implications of the LIFE trialSunil Nadar, Hoong Sern Lim, Gregory Y H LipPageof 289